首页> 外文期刊>Substance Abuse Treatment, Prevention, and Policy >Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016–2020
【24h】

Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016–2020

机译:临床和社会渗透因子对物质使用障碍患者疲劳的影响:2016 - 2016年期间挪威的队列研究

获取原文
           

摘要

The impact of clinical and sociodemographic factors on fatigue remains unknown among patients with substance use disorders (SUD). This study aims to evaluate fatigue among patients with SUD using a nine-item fatigue severity scale (FSS-9) and identify the impact that clinical and sociodemographic factors – such as injecting substance use, chronic infectious diseases, liver fibrosis, opioid agonist therapy (OAT), debt difficulties, and housing situation – have on fatigue. We used data from a cohort of patients with SUD in Norway with annual health assessments surveying FSS-9 and some clinical and sociodemographic factors. A total of 915 FSS-9 measurements were collected from 654 patients during the period 2016–2020. We defined baseline as the first annual health assessment when the health assessments were listed chronologically. Time was defined as years from baseline. We used a linear mixed model to analyse whether the clinical and sociodemographic factors affected the FSS-9 sum score, presented with beta coefficients (β) with 95% confidence intervals (CI). The mean sum score of the FSS-9 was 43 (standard deviation: 16) at baseline. Females compared with males (adjusted mean difference of FSS-9 sum score: 4.1, 95% CI: 1.3–7.0), having debt difficulties compared with having no debt difficulties (2.9;0.4–5.3), and frequent use of benzodiazepines (5.7;3.0–8.4) or amphetamines (-5.0;-8.0–?-2.0) compared to less frequent or no use of these substances changed the FSS-9 baseline sum score. The other clinical and sociodemographic factors did not predict any clinically relevant change in the FSS-9 sum score from baseline to the following health assessments. Patients with SUD suffer from high levels of fatigue. Female patients, patients with debt difficulties, and those with extensive use of benzodiazepines are at particular risk of being fatigued. This should be taken into consideration when planning health services.
机译:物质使用障碍(SUD)的患者中,临床和社会渗塑因子对疲劳的影响仍然是未知的。本研究旨在利用九项疲劳严重程度(FSS-9)评估Sud患者患者的疲劳,并确定临床和社会渗塑因素的影响 - 例如注射物质使用,慢性传染病,肝纤维化,阿片类激动剂治疗(燕麦),债务困难和住房局势 - 对疲劳进行了疲劳。我们使用从挪威苏打群组的患者的数据进行调查FSS-9和一些临床和社会造影因素的年度健康评估。在2016 - 2016年期间,从654名患者中收集了总共915个FSS-9测量。当按时间顺序上市时,我们将基线定义为第一届年度健康评估。时间是从基线的几年定义的。我们使用了线性混合模型来分析临床和社会渗目因素是否影响了FSS-9和评分,呈现出具有95%置信区间(CI)的β系数(β)。基线的FSS-9的平均和分数为43(标准差:16)。女性与男性相比(调整的FSS-9总和的平均差异:4.1,95%CI:1.3-7.0),与无债务困难相比,债务困难(2.9; 0.4-5.3),频繁使用苯二氮卓类动物(5.7 ; 3.0-8.4)或安非胺(-5.0; -8.0 - Δ-2.0)与少频繁或不使用这些物质,改变了FSS-9基线总和得分。其他临床和社会渗透因素未预测FSS-9的任何临床相关变化,从基线到以下健康评估。抑菌患者患有高水平的疲劳。女性患者,债务困难的患者,患有广泛使用苯二氮卓类动物的患者都特别有疲劳的风险。在规划卫生服务时,应考虑到这一点。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号